NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-116-2001-0-FI-46 Formulation of Boronic Acid Compounds FI EP 10006835.2 Expired
NCI E-116-2001-0-SE-57 Formulation of Boronic Acid Compounds SE EP 10006835.2 Expired
NCI E-116-2001-0-GB-48 Formulation of Boronic Acid Compounds GB EP 10006835.2 Expired
NCI E-116-2001-0-TR-58 Formulation of Boronic Acid Compounds TR EP 10006835.2 Expired
NCI E-116-2001-0-CH-41 Formulation of Boronic Acid Compounds CH EP 10006835.2 Expired
NCI E-116-2001-0-ES-45 Formulation of Boronic Acid Compounds ES EP 10006835.2 Expired
NCI E-116-2001-0-CA-13 Formulation of Boronic Acid Compounds CA National Stage 2435146 Expired
NCI E-116-2001-0-CY-20 Formulation of Boronic Acid Compounds CY EP 02709145.3 Expired
NCI E-116-2001-0-TR-32 Formulation of Boronic Acid Compounds TR EP 02709145.3 Expired
NCI E-116-2001-0-GB-36 Formulation of Boronic Acid Compounds GB EP 02709145.3 Expired
NCI E-116-2001-0-CH-19 Formulation of Boronic Acid Compounds CH EP 02709145.3 Expired
NCI E-116-2001-0-SE-31 Formulation of Boronic Acid Compounds SE EP 02709145.3 Expired
NCI E-116-2001-0-ES-23 Formulation of Boronic Acid Compounds ES EP 02709145.3 Expired
NCI E-116-2001-0-NL-29 Formulation of Boronic Acid Compounds NL EP 02709145.3 Expired
NCI E-116-2001-0-MC-28 Formulation of Boronic Acid Compounds MC EP 02709145.3 Expired
NCI E-116-2001-0-PT-30 Formulation of Boronic Acid Compounds PT EP 02709145.3 Expired
NCI E-116-2001-0-LI-26 Formulation of Boronic Acid Compounds LI EP 02709145.3 Expired
NCI E-116-2001-0-LU-27 Formulation of Boronic Acid Compounds LU EP 02709145.3 Expired
NCI E-116-2001-0-DK-22 Formulation of Boronic Acid Compounds DK EP 02709145.3 Expired
NCI E-116-2001-0-DE-21 Formulation of Boronic Acid Compounds DE EP 02709145.3 Expired
NCI E-116-2001-0-FR-35 Formulation of Boronic Acid Compounds FR EP 02709145.3 Expired
NCI E-116-2001-0-FI-34 Formulation of Boronic Acid Compounds FI EP 02709145.3 Expired
NCI E-116-2001-0-GR-37 Formulation of Boronic Acid Compounds GR EP 02709145.3 Expired
NCI E-116-2001-0-IT-25 Formulation of Boronic Acid Compounds IT EP 02709145.3 Expired
NCI E-116-2001-0-IE-24 Formulation of Boronic Acid Compounds IE EP 02709145.3 Expired
NCI E-116-2001-0-AT-17 Formulation of Boronic Acid Compounds AT EP 02709145.3 Expired
NCI E-116-2001-0-BE-18 Formulation of Boronic Acid Compounds BE EP 02709145.3 Expired
NCI E-116-2001-0-EP-11 Formulation of Boronic Acid Compounds EP National Stage 02709145.3 Expired
NCI E-154-1998-0-US-07 RECOMBINANT POX VIRUS FOR IMMUNIZATION AGAINST MUCI TUMOR-ASSOCIATED ANTIGEN US CON 10/057,136 7118738 Expired PDF
NCI E-116-2001-0-AU-10 Formulation of Boronic Acid Compounds AU National Stage 2002243646 Expired
NIDDK E-015-1996-0-US-08 FOLLICLE STIMULATING HORMONE SUPERAGONISTS US DIV 10/057,113 7070788 Expired PDF
NCI E-116-2001-0-US-03 Formulation of Boronic Acid Compounds US ORD 10/056,567 6713446 Expired PDF
NCI E-116-2001-0-US-02 Formulation of Boronic Acid Compounds US ORD 10/056,563 6699835 Expired PDF
NCI E-116-2001-0-PCT-04 Formulation of Boronic Acid Compounds PCT PCT PCT/US2002/002086 Expired
NCI E-116-2001-0-PCT-05 Formulation of Boronic Acid Compounds (NIH Filed) PCT PCT PCT/US2002/001907 Expired
NCI E-116-2001-0-EP-07 Formulation of Boronic Acid Compounds EP National Stage 02718868.9 Abandoned
NIDCR E-312-2000-0-PCT-02 Hybrid Adenoviral Vector PCT PCT PCT/US02/02279 Expired
NCI E-212-1999-2-US-06 Immunotherapy In HIV Infected Persons Using Vaccines after Multi-Drug Treatment US National Stage 10/048,072 Abandoned
NIDCR E-053-2002-0-US-01 Methods and composition For The Promotion of Hair growth Utilizing Act in Binding Peptides US 60/351,386 Abandoned
NIDCR E-263-2001-0-US-01 Bone-Forming Composition, Methods for Making and Methods of Use US 60/351,795 Abandoned
NCI E-116-2001-0-AU-06 Formulation of Boronic Acid Compounds AU National Stage 2002249979 Abandoned
NCI E-116-2001-0-CA-09 Formulation of Boronic Acid Compounds CA National Stage 2435124 Abandoned
NINDS E-278-2000-0-PCT-02 Differentiation of Stem Cells to Pancreatic Endocrine Cells PCT PCT PCT/US02/02361 Expired
NINDS E-278-2000-0-JP-06 Differentiation of Stem Cells to Pancreatic Endocrine Cells JP National Stage 2002-559565 Abandoned
NINDS E-278-2000-0-EP-05 Differentiation of Stem Cells to Pancreatic Endocrine Cells EP National Stage 02707587.8 Abandoned
NINDS E-278-2000-0-AU-07 Differentiation of Stem Cells to Pancreatic Endocrine Cells AU National Stage 2002241986 Abandoned
NINDS E-278-2000-0-CA-04 Differentiation of Stem Cells to Pancreatic Endocrine Cells CA National Stage 2435826 Abandoned
NCI E-290-2000-0-CA-04 Detection And Quantification of Cripto-1 CA National Stage 2434694 Expired
NCI E-290-2000-0-AU-05 Detection And Quantification of Cripto-1 AU National Stage 2002236871 Abandoned
NCI E-290-2000-0-ES-11 Detection And Quantification of Cripto-1 ES EP 02703238.2 Abandoned